[1] |
RAJU T N, MERCER B M, BURCHFIELD D J,et al. Periviable birth:executive summary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development,Society for Maternal-Fetal Medicine,American Academy of Pediatrics,and American College of Obstetricians and Gynecologists[J]. Am J Obstet Gynecol, 2014, 210(5):406-417. DOI: 10.1016/j.ajog.2014.02.027.
|
[2] |
|
[3] |
LUBBE W. Clinicians guide for cue-based transition to oral feeding in preterm infants:An easy-to-use clinical guide[J]. J Eval Clin Pract, 2018, 24(1):80-88. DOI: 10.1111/jep.12721.
|
[4] |
YOUNGE N, GOLDSTEIN R F, BANN C M,et al. Survival and neurodevelopmental outcomes among periviable infants[J]. N Engl J Med, 2017, 376(7):617-628. DOI: 10.1056/NEJMoa1605566.
|
[5] |
|
|
|
[6] |
|
[7] |
|
[8] |
SWEET D G, CARNIELLI V, GREISEN G,et al. European consensus guidelines on the management of respiratory distress syndrome-2019 update[J]. Neonatology, 2019, 115(4):432-450. DOI: 10.1159/000499361.
|
[9] |
SAUGSTAD O D. Oxygenation of the immature infant:a commentary and recommendations for oxygen saturation targets and alarm limits[J]. Neonatology, 2018, 114(1):69-75. DOI: 10.1159/000486751.
|
[10] |
|
[11] |
|
[12] |
OHLSSON A, WALIA R, SHAH S S. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight(or both)infants[J]. Cochrane Database Syst Rev, 2020, 2(2):CD003481. DOI: 10.1002/14651858.CD003481.pub7.
|
[13] |
GIBSON K S, BRACKNEY K. Periviable premature rupture of membranes[J]. Obstet Gynecol Clin North Am, 2020, 47(4):633-651. DOI: 10.1016/j.ogc.2020.08.007.
|
[14] |
OHLSSON A, LACY J B. Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants[J]. Cochrane Database Syst Rev, 2020, 1(1):CD000361. DOI: 10.1002/14651858.CD000361.pub4.
|
[15] |
|
[16] |
LING Q Y, CHEN H, TANG M,et al. Accuracy and safety study of intracavitary electrocardiographic guidance for peripherally inserted central catheter placement in neonates[J]. J Perinat Neonatal Nurs, 2019, 33(1):89-95. DOI: 10.1097/JPN.0000000000000389.
|
[17] |
|
[18] |
QUIGLEY M, EMBLETON N D, MCGUIRE W. Formula versus donor breast milk for feeding preterm or low birth weight infants[J]. Cochrane Database Syst Rev, 2018, 6(6):CD002971. DOI: 10.1002/14651858.CD002971.pub4.
|
[19] |
RAMEL S, RAO R. Hyperglycemia in extremely preterm infants[J]. Neoreviews, 2020, 21(2):e89-97. DOI: 10.1542/neo.21-2-e89.
|
[20] |
CHINOY A, MUGHAL M Z, PADIDELA R. Metabolic bone disease of prematurity-National survey of current neonatal and paediatric endocrine approaches[J]. Acta Paediatr, 2021, 110(6):1855-1862. DOI: 10.1111/apa.15654.
|
[21] |
IIJIMA S. Current knowledge of transient hypothyroxinemia of prematurity:to treat or not to treat?[J]. J Matern Fetal Neonatal Med, 2019, 32(15):2591-2597. DOI: 10.1080/14767058.2018.1441277.
|
[22] |
YOON S A, CHANG Y S, AHN S Y,et al. Incidence and severity of transient hypothyroxinaemia of prematurity associated with survival without composite morbidities in extremely low birth weight infants[J]. Sci Rep, 2019, 9(1):9628. DOI: 10.1038/s41598-019-46108-9.
|
[23] |
|
[24] |
|
[25] |
SAENZ P, CERDA M, DIAZ J L,et al. Psychological stress of parents of preterm infants enrolled in an early discharge programme from the neonatal intensive care unit:a prospective randomised trial[J]. Arch Dis Child Fetal Neonatal Ed, 2009, 94(2):F98-104. DOI: 10.1136/adc.2007.135921.
|
[26] |
|
[27] |
|
[28] |
SONG D L, JEGATHEESAN P, NAFDAY S,et al. Patterned frequency-modulated oral stimulation in preterm infants:a multicenter randomized controlled trial[J]. PLoS One, 2019, 14(2):e0212675. DOI: 10.1371/journal.pone.0212675
|
[29] |
EHRET D E Y, EDWARDS E M, GREENBERG L T,et al. Association of antenatal steroid exposure with survival among infants receiving postnatal life support at 22 to 25 weeks' gestation[J]. JAMA Netw Open, 2018, 1(6):e183235. DOI: 10.1001/jamanetworkopen.2018.3235.
|
[30] |
LEE P L, LEE W T, CHEN H L. Ventilator-associated pneumonia in low birth weight neonates at a neonatal intensive care unit:a retrospective observational study[J]. Pediatr Neonatol, 2017, 58(1):16-21. DOI: 10.1016/j.pedneo.2015.10.014.
|
[31] |
GILARD V, TEBANI A, BEKRI S,et al. Intraventricular hemorrhage in very preterm infants:a comprehensive review[J]. J Clin Med, 2020, 9(8):2447. DOI: 10.3390/jcm9082447.
|
[32] |
XIONG T, MAHESHWARI A, NEU J,et al. An overview of systematic reviews of randomized-controlled trials for preventing necrotizing enterocolitis in preterm infants[J]. Neonatology, 2020, 117(1):46-56. DOI: 10.1159/000504371.
|
[33] |
RAFFAY T M, DYLAG A M, DI FIORE J M,et al. S-nitrosoglutathione attenuates airway hyperresponsiveness in murine bronchopulmonary dysplasia[J]. Mol Pharmacol, 2016, 90(4):418-426. DOI: 10.1124/mol.116.104125.
|
[34] |
DOYLE L W, CHEONG J L, EHRENKRANZ R A,et al. Early (<8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants[J]. Cochrane Database Syst Rev, 2017, 10(10):CD001146. DOI: 10.1002/14651858.CD001146.pub5.
|
[35] |
BAUD O, TROUSSON C, BIRAN V,et al. Two-year neurodevelopmental outcomes of extremely preterm infants treated with early hydrocortisone:treatment effect according to gestational age at birth[J]. Arch Dis Child Fetal Neonatal Ed, 2019, 104(1):F30-35. DOI: 10.1136/archdischild-2017-313756.
|
[36] |
GILFILLAN M, BHANDARI A, BHANDARI V. Diagnosis and management of bronchopulmonary dysplasia[J]. BMJ, 2021, 375:n1974. DOI: 10.1136/bmj.n1974.
|